-
Development of a Cardiac Catheterization Laboratory Nursing Program Targeting Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Delphi Study
-
Peripheral Intravenous Catheters in Hospitalized Surgical Patients: A US Real-World Data Analysis
-
Real-World Treatment Patterns in Patients with Atopic Dermatitis Initiating Ruxolitinib Cream: A 12-Month Follow-Up Analysis of a US Payer Claims Database
-
Real-World Health Care Resource Utilization and Economic Burden Among Patients with Idiopathic Pulmonary Fibrosis in Commercially Insured and Medicare Advantage Populations in the United States
-
Contemporary Percutaneous Management of Saphenous Vein Graft Lesions: Practical Strategies and Emerging Technologies
-
First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs
-
Epidemiology, Patient Characteristics, Real-World Treatment Patterns, and Healthcare Utilization and Spending for Patients with Multifocal Motor Neuropathy: A US Claims-Based Analysis
-
Trends and Racial‐Geographic Disparities in Coexisting Coronary Artery Disease (CAD) and Heart Failure (HF) Related Mortality Among U.S. Adults, 1999–2024
-
Multi‐Omics Biomarkers From Variant to Clinic: A Systematic Review and Meta‐Analysis of Evidence, AI/ML, Governance, Equity, and Real‐World Implementation Across Global Health Systems
-
Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United States
-
Real‑World Clinical Characterization of Major Depressive Disorder and Treatment‑Resistant Depression Supported by Natural Language Processing: Multicenter Observational Study From the MOOD Project
-
Validation of the Medicare-Enhanced Laboratory and Demographics (MELD™) Dataset: A Comprehensive Psychometric, Epidemiologic, and Predictive-Utility Assessment of a 60-Million-Patient Real-World Evidence Resource
-
Economic Burden of COVID-19 Hospitalization in Almaty, Kazakhstan
-
Real-World Treatment Landscape of Individuals with Rett Syndrome Treated and Untreated with Trofinetide in the United States
-
Atherogenic Index of Plasma’s Association with Coronary Heart Disease Risks Among Postmenopausal Pakistani Women
-
Association of Simulation-Based Team Training Implementation with Treatment Process Optimization and Clinical Outcomes in a Chest Pain Center: A Retrospective Pre-Post Analysis of Real-World Data
-
Early Health Technology Assessment (HTA) of Olpasiran and Pelacarsen for Secondary Prevention of Coronary Heart Disease (CHD)
-
Peripheral T-cell Lymphoma in Japan: Real-World Patient Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs
-
The Effectiveness and Current Challenges of Home-Based Cardiac Telerehabilitation for Patients with Coronary Artery Disease: A Narrative Review
-
Healthcare Utilization and Costs After Appropriate or Inappropriate Implantable Defibrillator Shocks: A Retrospective Real-World Data Study in Japan
-
Social Impact and Economic Burden of Uncoded Hyponatremia in Elderly – A Cost-of-Illness Study
-
Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italy
-
The Global Burden of Aortic Aneurysm and Its Attributable Risk Factors, 1990–2021: Results from the Global Burden of Disease Study 2021
-
Advancing Health Equity in the US Military
